Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
622
-
Share change
-
-68,084,652
-
Total reported value
-
$42,068
-
Price per share
-
$67.82
-
Number of holders
-
2
-
Value change
-
-$4,636,555,323
-
Number of sells
-
227
Institutional Holders of GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) as of Q4 2022
As of 31 Dec 2022,
GLOBAL BLOOD THERAPEUTICS INC - COMMON STOCK (GBT) was held by
2 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
622 shares.
The largest 2 holders included
Ronald Blue Trust, Inc. and HUNTINGTON NATIONAL BANK.
This page lists
2
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.